ZYROP 40000 VIAL INJECTION 2 ML

ZYROP 40000 VIAL INJECTION 2 ML

By ZYDUS LIFESCIENCES LIMITED

MRP 1389
111120% OFF
Not for Online Sale
8 Alternative Available arrow
Medicines with same composition as ZYROP 40000 VIAL INJECTION 2 ML

About ZYROP 40000 VIAL INJECTION 2 ML

  • ZYROP 40000 VIAL INJECTION 2 ML (EPO) is a glycoprotein hormone primarily produced by the kidneys, with a minor amount produced by the liver. It plays a crucial role in regulating red blood cell production, known as erythropoiesis. EPO stimulates the bone marrow to produce red blood cells, which are responsible for carrying oxygen throughout the body. It is used in the treatment of various conditions associated with anemia, such as chronic kidney disease, cancer-related anemia, and certain blood disorders.

Uses of ZYROP 40000 VIAL INJECTION 2 ML

  • Helps in anemia treatment
  • Used in chronic kidney disease
  • Treats blood disorders

How ZYROP 40000 VIAL INJECTION 2 ML Works

  • ZYROP 40000 VIAL INJECTION 2 ML stimulates the production of red blood cells in the bone marrow, increasing oxygen-carrying capacity and improving anemia.
  • ZYROP 40000 VIAL INJECTION 2 ML binds to specific receptors on the surface of progenitor cells in the bone marrow. This interaction triggers a signaling cascade, leading to the activation of genes involved in erythropoiesis. As a result, more red blood cells are produced from the bone marrow, maturing and entering the bloodstream. ZYROP 40000 VIAL INJECTION 2 ML also enhances the survival of these red blood cells by reducing apoptosis. The increased red blood cell count improves the oxygen-carrying capacity, alleviating anemia and improving tissue oxygenation. Furthermore, ZYROP 40000 VIAL INJECTION 2 ML has been shown to stimulate the release of reticulocytes, which are young red blood cells, from the bone marrow, further contributing to the replenishment of red blood cells in the circulation.

Dosage of ZYROP 40000 VIAL INJECTION 2 ML Works

  • Dosage for Children: The dosage of ZYROP 40000 VIAL INJECTION 2 ML for children varies depending on their age, weight, and specific medical condition. It should be determined by a pediatrician or healthcare professional.
  • Dosage for Adults: The recommended dosage of ZYROP 40000 VIAL INJECTION 2 ML for adults also varies depending on the underlying condition being treated. It should be prescribed and monitored by a healthcare professional.

Side Effects Of ZYROP 40000 VIAL INJECTION 2 ML

Common Side Effects of ZYROP 40000 VIAL INJECTION 2 ML
  • Hypertension
  • Thrombosis
  • Headache
  • Fatigue

How to Store ZYROP 40000 VIAL INJECTION 2 ML

  • Store in refrigerator (2-8°C)
  • Protect from light

Frequently asked questions about ZYROP 40000 VIAL INJECTION 2 ML

Common side effects of ZYROP 40000 VIAL INJECTION 2 ML include hypertension, thrombosis, headache, and fatigue.

ZYROP 40000 VIAL INJECTION 2 ML is primarily used in the treatment of anemia associated with chronic kidney disease, cancer-related anemia, and certain blood disorders.

ZYROP 40000 VIAL INJECTION 2 ML should only be used during pregnancy if the potential benefits outweigh the risks. Consult with a healthcare professional for guidance.

ZYROP 40000 VIAL INJECTION 2 ML can be administered through injections under the skin (subcutaneous) or directly into a vein (intravenous).

In some cases, ZYROP 40000 VIAL INJECTION 2 ML can be self-administered at home after appropriate training and under the guidance of a healthcare professional.

The time for ZYROP 40000 VIAL INJECTION 2 ML to show its effects may vary. Consult with a healthcare professional for a personalized assessment.

ZYROP 40000 VIAL INJECTION 2 ML may interact with certain medications, such as immunosuppressants or anticoagulants. Inform your healthcare provider about all medications you are taking.

The misuse of ZYROP 40000 VIAL INJECTION 2 ML in sports is considered doping and is strictly prohibited. Athletes should adhere to anti-doping regulations and ethical standards.

References related to ZYROP 40000 VIAL INJECTION 2 ML

  1. Okusa, M. D., & Balogun, R. A. (2010). Pharmacological Interventions in Acute Kidney Injury. 677–686. https://doi.org/10.1016/b978-1-4377-0987-2.00049-2 image
Customer Reviews

Patel Jinal

Good place to buy generic medicines

Reviewed on 24 May 2023

Patel Jinal

Reviewed on 24 May 2023

Good place to buy generic medicines

shilpa purohit

Value for money I got a good discount on medicines

Reviewed on 04 Sep 2023

shilpa purohit

Reviewed on 04 Sep 2023

Value for money I got a good discount on medicines

ALIMAMY ABDULAI JALLOH

Quality products and services offered. 🥰

Reviewed on 08 Feb 2024

ALIMAMY ABDULAI JALLOH

Reviewed on 08 Feb 2024

Quality products and services offered. 🥰

Narmawala Anzar Mo.Ilyas

Generic medicines at reasonable rates.

Reviewed on 22 Apr 2024

Narmawala Anzar Mo.Ilyas

Reviewed on 22 Apr 2024

Generic medicines at reasonable rates.

PRASHANT KATARIYA

Great experience👍🏻

Reviewed on 29 Jan 2024

PRASHANT KATARIYA

Reviewed on 29 Jan 2024

Great experience👍🏻

See More Reviews